v3.24.3
Stock-Based Compensation Expense (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Restricted Stock Unit Activity

A summary of the restricted stock unit activity under the Plans for the nine months ended September 30, 2024 was as follows:

 

 

Shares

 

 

Weighted-
Average
Grant Date Fair Value

 

Restricted stock units outstanding as of December 31, 2023

 

 

105,048

 

 

$

3.20

 

Granted

 

 

984,929

 

 

$

5.49

 

Vested

 

 

(27,869

)

 

$

3.29

 

Forfeited

 

 

(194,636

)

 

$

4.28

 

Restricted stock units outstanding as of September 30, 2024

 

 

867,472

 

 

$

5.56

 

 

Summary of Stock Option Activity Under Plans

A summary of the stock option activity under the Plans for the nine months ended September 30, 2024 was as follows:

 

 

Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2023

 

 

5,709,980

 

 

$

5.68

 

 

 

8.0

 

 

$

6,334

 

Granted

 

 

2,605,002

 

 

 

4.89

 

 

 

 

 

 

 

Exercised

 

 

(1,002

)

 

 

3.96

 

 

 

 

 

 

 

Cancelled

 

 

(1,926,891

)

 

 

4.83

 

 

 

 

 

 

 

Outstanding at September 30, 2024

 

 

6,387,089

 

 

$

5.61

 

 

 

7.9

 

 

$

 

Schedule of Fair Value of Stock Option Estimated on Date of Grant Using Black-Scholes Option-Pricing Model or Monte Carlo Simulation in Case of Certain Options Granted to Executive Officers

The fair value of each stock option granted to employees, directors and non-employees was estimated on the date of grant using the Black-Scholes option-pricing model, or a Monte Carlo simulation in the case of certain options granted to executive officers, with the following weighted-average assumptions for the three and nine months ended September 30, 2024 and 2023:

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Risk-free interest rate

 

 

0.0

%

 

 

4.3

%

 

 

4.2

%

 

 

3.7

%

Expected dividend yield

 

 

%

 

 

%

 

 

%

 

 

%

Expected term (in years)

 

 

 

 

 

6.1

 

 

 

6.0

 

 

 

6.0

 

Expected volatility

 

 

0.0

%

 

 

80.0

%

 

 

80.5

%

 

 

82.9

%

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense included in the Company’s consolidated statements of operations and comprehensive loss was as follows (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

 

$

214

 

 

$

294

 

 

$

627

 

 

$

865

 

General and administrative

 

 

1,277

 

 

 

1,147

 

 

 

4,150

 

 

 

3,540

 

Total

 

$

1,491

 

 

$

1,441

 

 

$

4,777

 

 

$

4,405